Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8555877 Nasal delivery device

Patent 8555877 was granted and assigned to OptiNose on October, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

OptiNose

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

85558770

Date of Patent

October 15, 2013

Patent Application Number

114458120

Date Filed

June 2, 2006

Patent Citations Received

‌

US Patent 12083270 Delivery device and method

‌

US Patent 11878110 Intranasal device with inlet interface

‌

US Patent 11878109 Single-use nasal delivery device

‌

US Patent 11890412 Nozzles for nasal drug delivery

‌

US Patent 11690819 Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease

‌

US Patent 11690969 Delivery of gases to the nasal airway

‌

US Patent 11707586 Intranasal administration

‌

US Patent 11752100 Intranasal delivery of olanzapine by precision olfactory device

...

Patent Primary Examiner

‌

Gary Jackson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8555877 Nasal delivery device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API